Healthcare Realty Trust (NYSE:HR) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Healthcare Realty Trust (NYSE:HR) issued its quarterly earnings results on Wednesday. The real estate investment trust reported $0.40 EPS for the quarter, topping the consensus estimate of $0.39 by $0.01, Zacks reports. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust updated its FY 2025 guidance to 1.560-1.600 EPS.

Healthcare Realty Trust Stock Performance

Shares of HR opened at $16.88 on Wednesday. Healthcare Realty Trust has a twelve month low of $12.77 and a twelve month high of $18.90. The firm’s 50 day moving average price is $16.69 and its two-hundred day moving average price is $17.42. The firm has a market cap of $5.98 billion, a P/E ratio of -10.64 and a beta of 0.94.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 7,750 shares of the business’s stock in a transaction dated Friday, November 22nd. The shares were acquired at an average price of $17.39 per share, with a total value of $134,772.50. Following the completion of the transaction, the director now directly owns 50,002 shares in the company, valued at $869,534.78. This trade represents a 18.34 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Peter F. Sr Lyle, Sr. acquired 10,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the transaction, the director now owns 26,576 shares of the company’s stock, valued at $457,372.96. This represents a 60.33 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 18,750 shares of company stock valued at $323,723. 0.56% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $18.00 to $16.00 in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research note on Friday, December 20th. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $17.00.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.